Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

HALO

Halozyme Therapeutics Inc

May 29 • 04:00PM ET

66.54

-1.64 -2.41 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: TECH RGEN CRL BRKR ICLR MEDP BIO A IQV MTD

| Held by: IJH VTI VB XBI VBK VXF FBT MDY IBB XMHQ

Scroll to Statements

Index	-	P/E	23.93	EPS (ttm)	2.78	Insider Own	1.04%	Shs Outstand	118.52M	Perf Week	-2.89%
Market Cap	7.89B	Forward P/E	6.70	EPS next Y	9.93	Insider Trans	-17.08%	Shs Float	117.38M	Perf Month	5.52%
Enterprise Value	9.72B	PEG	0.17	EPS next Q	1.81	Inst Own	104.33%	Short Float	11.41%	Perf Quarter	-4.30%
Income	348.84M	P/S	5.23	EPS this Y	95.41%	Inst Trans	-1.04%	Short Ratio	8.35	Perf Half Y	-8.62%
Sales	1.51B	P/B	35.91	EPS next Y	22.41%	ROA	14.33%	Short Interest	13.39M	Perf YTD	-1.13%
Book/sh	1.85	P/C	24.77	EPS next 5Y	39.10%	ROE	99.40%	52W High	82.22 -19.07%	Perf Year	21.58%
Cash/sh	2.69	P/FCF	11.82	EPS past 3/5Y	21.17% 22.89%	ROIC	16.18%	52W Low	51.06 30.32%	Perf 3Y	100.42%
Dividend Est.	-	EV/EBITDA	10.12	Sales past 3/5Y	28.38% 39.16%	Gross Margin	76.93%	Volatility	2.25% 3.54%	Perf 5Y	60.69%
Dividend TTM	-	EV/Sales	6.44	EPS Y/Y TTM	-24.20%	Oper. Margin	56.96%	ATR (14)	2.22	Perf 10Y	565.40%
Dividend Ex-Date	-	Quick Ratio	2.33	Sales Y/Y TTM	39.12%	Profit Margin	23.13%	RSI (14)	46.68	Recom	2.09
Dividend Gr. 3/5Y	- -	Current Ratio	2.76	EPS Q/Q	30.96%	SMA20	-1.26%	Beta	0.88	Target Price	83.90
Payout	0.00%	Debt/Eq	9.76	Sales Q/Q	42.23%	SMA50	0.73%	Rel Volume	1.19	Prev Close	68.18
Employees	423	LT Debt/Eq	8.81	Earnings	May 11 AMC	SMA200	-3.87%	Avg Volume	1.60M	Price	66.54
IPO	Mar 12, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.56% 5.05%	Trades		Volume	1,909,394	Change	-2.41%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)